The transcription factor CCAAT enhancer binding protein alpha (CEBPA) [12] is crucial for normal development of granulocytes and there is evidence that impaired CEBPA function contributes directly to the development of AML [13]. This evidence concerns the gene CEBPA and acute myeloid leukemia.